Nifty

:

26172.40

Sensex

:

85567.48

206.00 (0.79%)
638.12 (0.75%)

Login

Nifty
Sensex

:
:

26172.40
85567.48

206.00 (0.79%)
638.12 (0.75%)

Auro Laboratories Ltd.

Pharmaceuticals & Drugs

Rating :

54/99

BSE: 530233 | NSE: Not Listed

Watchlist

NSE BSE

251.70

19-Dec-2025

Open
High
Low
Previous Close

246.25
258
246.25
247.25

Volume
Traded Value (lacs)
52 Week High
52 Week Low

7133
1809986
258
0

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

156.87
148.41
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

200.15
N/A
3.60

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-3.57
-18.59
-28.42

EBITDA CAGR (%)

10 Years
5 Years
3 Years

1.99
-21.22
-4.93

PAT CAGR (%)

10 Years
5 Years
3 Years

7.65
-23.84
-8.98

P:E (Median)

8 Years
5 Years
3 Years

14.37
19.06
23.86

P:BV (Average)

8 Years
5 Years
3 Years

2.34
2.48
2.69

EV:EBITDA (Average)

8 Years
5 Years
3 Years

12.34
16.00
21.66

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 8.84 3.10 185.16% 2.77 5.72 -51.57% 7.40 12.06 -38.64% 3.06 17.98 -82.98%
Expenses 6.48 2.38 172.27% 2.74 4.40 -37.73% 6.59 9.65 -31.71% 2.61 13.90 -81.22%
EBITDA 2.36 0.72 227.78% 0.03 1.32 -97.73% 0.81 2.41 -66.39% 0.44 4.08 -89.22%
EBIDTM 26.67% 23.32% 1.23% 23.13% 11.00% 19.97% 14.50% 22.69%
Other Income 0.98 0.31 216.13% 0.42 0.20 110.00% 0.13 0.40 -67.50% 0.14 0.42 -66.67%
Interest 0.96 0.28 242.86% 0.28 0.25 12.00% 0.30 -0.33 - 0.25 0.45 -44.44%
Depreciation 0.65 0.27 140.74% 0.27 0.27 0.00% 0.29 0.28 3.57% 0.27 0.27 0.00%
PBT 1.72 0.48 258.33% -0.11 1.01 - 0.35 2.85 -87.72% 0.07 3.79 -98.15%
Tax 1.00 0.12 733.33% 0.00 0.25 -100.00% -0.04 0.53 - 0.02 1.05 -98.10%
PAT 0.72 0.36 100.00% -0.11 0.75 - 0.40 2.32 -82.76% 0.05 2.73 -98.17%
PATM 8.10% 11.58% -3.79% 13.16% 5.34% 19.23% 1.67% 15.21%
EPS 1.15 0.58 98.28% -0.17 1.21 - 0.64 3.74 -82.89% 0.08 4.41 -98.19%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 22.07 19.40 53.64 52.89 50.87 54.25 43.79 46.82 40.79 35.47 27.91 Net Sales Growth -43.21% -63.83% 1.42% 3.97% -6.23% 23.89% -6.47% 14.78% 15.00% 27.09% Cost Of Goods Sold 10.30 9.21 26.56 35.69 32.78 28.55 24.48 28.62 24.72 22.42 18.14 Gross Profit 11.77 10.19 27.08 17.20 18.08 25.70 19.31 18.20 16.07 13.06 9.77 GP Margin 53.35% 52.53% 50.48% 32.52% 35.54% 47.37% 44.10% 38.87% 39.40% 36.82% 35.01% Total Expenditure 18.42 15.99 42.97 48.50 46.24 43.01 37.52 39.83 34.44 31.05 25.11 Power & Fuel Cost - 0.33 2.43 2.08 1.67 1.60 1.69 1.64 1.48 1.29 1.02 % Of Sales - 1.70% 4.53% 3.93% 3.28% 2.95% 3.86% 3.50% 3.63% 3.64% 3.65% Employee Cost - 2.47 3.91 3.76 3.69 3.63 3.47 2.87 2.79 2.71 2.37 % Of Sales - 12.73% 7.29% 7.11% 7.25% 6.69% 7.92% 6.13% 6.84% 7.64% 8.49% Manufacturing Exp. - 0.78 1.60 1.47 1.65 2.09 1.72 1.32 1.25 1.24 1.02 % Of Sales - 4.02% 2.98% 2.78% 3.24% 3.85% 3.93% 2.82% 3.06% 3.50% 3.65% General & Admin Exp. - 1.19 3.59 2.46 3.46 3.39 3.44 2.48 1.96 1.28 0.78 % Of Sales - 6.13% 6.69% 4.65% 6.80% 6.25% 7.86% 5.30% 4.81% 3.61% 2.79% Selling & Distn. Exp. - 1.01 3.28 2.23 2.51 2.45 1.48 1.75 1.29 1.16 1.25 % Of Sales - 5.21% 6.11% 4.22% 4.93% 4.52% 3.38% 3.74% 3.16% 3.27% 4.48% Miscellaneous Exp. - 1.01 1.60 0.82 0.48 1.29 1.23 1.16 0.96 0.94 1.25 % Of Sales - 5.21% 2.98% 1.55% 0.94% 2.38% 2.81% 2.48% 2.35% 2.65% 1.90% EBITDA 3.64 3.41 10.67 4.39 4.63 11.24 6.27 6.99 6.35 4.42 2.80 EBITDA Margin 16.49% 17.58% 19.89% 8.30% 9.10% 20.72% 14.32% 14.93% 15.57% 12.46% 10.03% Other Income 1.67 0.66 1.50 0.94 1.09 0.76 0.97 0.96 0.51 0.53 0.42 Interest 1.79 1.08 0.74 0.81 0.83 0.46 0.58 0.87 1.21 1.18 1.66 Depreciation 1.48 1.10 1.09 1.07 1.02 1.04 1.02 1.01 0.93 0.86 0.68 PBT 2.03 1.88 10.35 3.45 3.87 10.51 5.64 6.07 4.73 2.92 0.88 Tax 0.98 0.04 2.55 1.00 1.03 3.33 1.59 1.67 1.20 2.11 0.00 Tax Rate 48.28% 2.13% 24.64% 28.99% 26.61% 31.68% 28.19% 27.51% 25.37% 72.26% 0.00% PAT 1.06 1.84 7.79 2.44 2.84 7.18 4.05 4.40 3.53 0.82 0.88 PAT before Minority Interest 1.06 1.84 7.79 2.44 2.84 7.18 4.05 4.40 3.53 0.82 0.88 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 4.80% 9.48% 14.52% 4.61% 5.58% 13.24% 9.25% 9.40% 8.65% 2.31% 3.15% PAT Growth -82.79% -76.38% 219.26% -14.08% -60.45% 77.28% -7.95% 24.65% 330.49% -6.82% EPS 1.71 2.97 12.56 3.94 4.58 11.58 6.53 7.10 5.69 1.32 1.42

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 42.97 41.96 34.20 31.52 28.58 21.50 17.41 12.98 9.41 8.59 Share Capital 6.23 6.23 6.23 6.23 6.23 6.23 6.23 6.23 6.23 6.23 Total Reserves 36.74 35.73 27.97 25.29 22.35 15.27 11.18 6.75 3.18 2.35 Non-Current Liabilities 34.49 19.84 3.66 3.31 4.07 4.72 6.06 7.89 11.40 7.23 Secured Loans 30.79 18.38 1.76 0.85 1.27 1.81 2.62 3.43 4.95 0.00 Unsecured Loans 2.30 0.00 0.26 0.81 1.12 1.35 1.95 3.02 4.93 7.23 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 21.64 23.93 18.13 20.13 9.24 6.14 9.99 9.54 5.99 9.88 Trade Payables 6.21 6.20 11.48 4.86 5.75 4.74 5.18 5.30 4.93 3.58 Other Current Liabilities 4.94 6.46 0.73 1.37 1.17 0.79 0.83 1.48 1.06 0.90 Short Term Borrowings 10.39 7.80 4.26 11.79 0.66 0.00 3.53 2.75 0.00 5.39 Short Term Provisions 0.10 3.47 1.66 2.11 1.65 0.61 0.45 0.00 0.00 0.00 Total Liabilities 99.10 85.73 55.99 54.96 41.89 32.36 33.46 30.41 26.80 25.70 Net Block 21.06 22.15 12.62 13.61 13.56 14.24 14.59 13.02 13.00 9.13 Gross Block 36.10 36.10 25.47 25.39 24.32 23.96 23.29 20.72 19.76 15.50 Accumulated Depreciation 15.04 13.95 12.85 11.78 10.76 9.73 8.70 7.69 6.76 6.37 Non Current Assets 77.58 54.88 20.33 17.61 13.94 14.40 14.75 14.74 13.28 13.25 Capital Work in Progress 56.48 32.68 7.67 3.67 0.13 0.12 0.12 1.07 0.23 3.33 Non Current Investment 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 Long Term Loans & Adv. 0.00 0.00 0.00 0.28 0.20 0.00 0.00 0.59 0.00 0.74 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 21.51 30.85 35.66 37.35 27.96 17.95 18.71 15.67 13.53 12.45 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 3.67 8.24 11.76 4.25 2.55 4.06 3.37 1.49 1.33 4.31 Sundry Debtors 9.39 13.39 12.40 13.61 7.30 5.78 8.50 8.37 7.69 5.05 Cash & Bank 0.63 1.65 2.42 12.40 14.54 5.68 4.11 2.25 1.01 0.53 Other Current Assets 7.83 0.87 1.07 4.87 3.58 2.42 2.73 3.56 3.51 2.55 Short Term Loans & Adv. 6.91 6.70 8.01 2.22 0.08 0.48 0.28 0.27 1.10 0.26 Net Current Assets -0.13 6.92 17.53 17.22 18.72 11.81 8.72 6.13 7.54 2.57 Total Assets 99.09 85.73 55.99 54.96 41.90 32.35 33.46 30.41 26.81 25.70

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 5.75 18.81 3.28 -6.59 12.82 9.30 6.87 4.77 5.85 7.88 PBT 1.88 10.35 3.45 3.87 10.51 5.64 6.07 4.73 2.92 0.88 Adjustment 1.90 2.08 2.13 1.60 1.33 1.64 1.72 2.02 1.88 2.16 Changes in Working Capital 1.96 6.38 -2.30 -12.07 0.98 2.02 -0.92 -0.69 1.68 4.84 Cash after chg. in Working capital 5.75 18.81 3.28 -6.59 12.82 9.30 6.87 6.05 6.49 7.88 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1.28 -0.64 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -24.45 -38.67 -5.08 -5.34 -3.51 -2.21 -3.19 -1.75 -1.56 -2.44 Net Fixed Assets -23.80 -35.64 -4.08 -4.61 -0.37 -0.67 -1.62 -1.80 -1.16 -2.52 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others -0.65 -3.03 -1.00 -0.73 -3.14 -1.54 -1.57 0.05 -0.40 0.08 Cash from Financing Activity 17.69 19.09 -8.18 9.79 -0.46 -5.52 -1.83 -1.77 -3.81 -5.34 Net Cash Inflow / Outflow -1.02 -0.77 -9.98 -2.14 8.85 1.58 1.86 1.24 0.47 0.09 Opening Cash & Equivalents 1.65 2.42 12.40 14.54 5.68 4.11 2.25 1.01 0.53 0.44 Closing Cash & Equivalent 0.63 1.65 2.42 12.40 14.54 5.68 4.11 2.25 1.01 0.53

Financial Ratios

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 68.94 67.32 54.87 50.58 45.86 34.49 27.94 20.82 15.10 13.78 ROA 1.99% 11.00% 4.40% 5.87% 19.34% 12.32% 13.78% 12.34% 3.11% 3.24% ROE 4.33% 20.46% 7.43% 9.47% 28.67% 20.84% 28.95% 31.53% 9.06% 10.83% ROCE 3.79% 20.37% 9.92% 12.20% 38.88% 24.80% 29.12% 28.65% 20.24% 11.21% Fixed Asset Turnover 0.54 1.74 2.08 2.05 2.25 1.85 2.13 2.02 2.10 1.90 Receivable days 214.37 87.78 89.77 75.03 44.00 59.53 65.79 71.86 62.81 83.84 Inventory Days 112.03 68.04 55.24 24.40 22.23 30.99 18.96 12.60 27.79 61.30 Payable days 246.16 121.53 83.56 59.08 67.05 51.48 47.58 55.90 51.82 53.73 Cash Conversion Cycle 80.24 34.28 61.45 40.35 -0.82 39.04 37.17 28.56 38.78 91.41 Total Debt/Equity 1.05 0.63 0.19 0.44 0.11 0.15 0.46 0.71 1.05 1.47 Interest Cover 2.74 15.06 5.23 5.69 23.92 10.76 7.95 4.90 3.49 1.53

Top Investors:

kirtilaben jayantilal mehta

samir jitendra javeri

ravi parimal shah

Annual Reports:

News Update:

Auro Laboratories gets WHO-GMP certificate for Tarapur API manufacturing facility
13th Nov 2025, 09:12 AM

The certificate is valid up to September 30, 2028
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback